+254745601747

info@clinicalmedhub.com

Nairobi, Kenya

Clopidogrel - Drug Details

Clopidogrel (Plavix)

Classification
Antiplatelet Agent
Mechanism of Action
Indications
Prevention of stroke, myocardial infarction, peripheral arterial disease
Dosage and Administration
75 mg once daily
Forms
Tablet
Side Effects
Bleeding, bruising, gastrointestinal upset
Contraindications
Active bleeding, peptic ulcer, intracranial hemorrhage
Interactions
Increased bleeding risk with anticoagulants and NSAIDs
Precautions
Monitor for signs of bleeding, use with caution in patients at risk of bleeding
Pharmacokinetics
Metabolized in the liver, excreted in urine and feces
Pharmacodynamics
Prevents blood clots by inhibiting platelet aggregation
Storage Requirements
Store at room temperature, away from moisture
Patient Counselling
Inform your doctor about any unusual bleeding or bruising
Back to List
ClinicalMedHub - Modern Footer

ClinicalMedHub

Comprehensive medical resources, research tools, and professional networking for healthcare providers and patients worldwide.

Scroll down to see the modern footer design